Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2432060120
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oude Engberink, R. D.
Right arrow Articles by Blezer, E. L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oude Engberink, R. D.
Right arrow Articles by Blezer, E. L. A.
(Radiology 2007;243:467-474.)
© RSNA, 2007


Molecular Imaging

Comparison of SPIO and USPIO for in Vitro Labeling of Human Monocytes: MR Detection and Cell Function1

Raoul D. Oude Engberink, MSc, Susanne M. A. van der Pol, Ed A. Döpp, Helga E. de Vries, PhD, and Erwin L. A. Blezer, PhD

1 From the Image Sciences Institute, University Medical Center Utrecht, Bolognalaan 50, 3584 CJ Utrecht, the Netherlands (R.D.O.E., E.L.A.B.); and Department of Molecular Cell Biology and Immunology, VU Medical Center, Amsterdam, the Netherlands (S.M.A.v.d.P., E.D., H.E.d.V.). Received January 20, 2006; revision requested March 22; revision received April 20; accepted May 17; final version accepted September 18. Supported by the Dutch MS Research Foundation (MS 01-470) and the European Commission (HPRI-CT-2001-50028). Address correspondence to R.D.O.E. (e-mail: raoul{at}invivonmr.uu.nl).

Purpose: To label human monocytes with superparamagnetic iron oxide (SPIO) and compare labeling efficiency with that of ultrasmall SPIO (USPIO) and evaluate the effect of iron incorporation on cell viability, migratory capacity, and proinflammatory cytokine production.

Materials and Methods: The study was approved by the institutional ethics committee; informed consent was obtained from donors. Freshly isolated human monocytes were labeled with iron particles of two sizes, USPIOs of 30 nm and SPIOs of 150 nm, for 1.5 hours in culture medium containing 0.1, 0.5, 1.0, and 3.7 mg of iron per milliliter. Labeling efficiency was determined with relaxation time magnetic resonance (MR) imaging (4.7 T) and Prussian blue staining for presence of intracellular iron. Cell viability was monitored; migratory capacity of monocytes after labeling was evaluated by using an in vitro assay with monolayers of brain endothelial cells. Levels of proinflammatory cytokines, interleukin (IL) 1 and IL-6, were measured with enzyme-linked immunosorbent assay 24 hours after labeling. Data were analyzed with Student t test or two-way analysis of variance followed by a multiple-comparison procedure.

Results: R2 relaxation rates increased for cell samples incubated with SPIOs, whereas rates were not affected for samples incubated with highest concentration of USPIOs. Labeling monocytes with SPIOs (1.0 mg Fe/mL) resulted in an R2 of 13.1 sec–1 ± 0.8 (standard error of the mean) (7 sec–1 ± 0.2 for vehicle-treated cells, P < .05) and had no effect on cell viability. On the basis of T2 relaxation times, the in vitro MR detection limit of 58 labeled monocytes per 0.05 µL was calculated. Migration of labeled monocytes was not different from that of vehicle-treated cells. Intracellular iron had no effect on production of IL-1 and IL-6 24 hours after labeling.

Conclusion: In vitro labeling of human monocytes is effective by using SPIOs, not USPIOs. Incubation with SPIOs (1.0 mg Fe/mL) results in efficient labeling detectable on MR images and does not affect cellular viability and activation markers such as cell migration and cytokine production.

© RSNA, 2007




This article has been cited by other articles:


Home page
CirculationHome page
Q. Ye, Y. L. Wu, L. M. Foley, T. K. Hitchens, D. F. Eytan, H. Shirwan, and C. Ho
Longitudinal Tracking of Recipient Macrophages in a Rat Chronic Cardiac Allograft Rejection Model With Noninvasive Magnetic Resonance Imaging Using Micrometer-Sized Paramagnetic Iron Oxide Particles
Circulation, July 8, 2008; 118(2): 149 - 156.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. M. Vellinga, R. D. Oude Engberink, A. Seewann, P. J.W. Pouwels, M. P. Wattjes, S. M.A. van der Pol, C. Pering, C. H. Polman, H. E. de Vries, J. J.G. Geurts, et al.
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement
Brain, March 1, 2008; 131(3): 800 - 807.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. J. Wu, L. L. Muldoon, C. Varallyay, S. Markwardt, R. E. Jones, and E. A. Neuwelt
In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging
Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1698 - C1708.
[Abstract] [Full Text] [PDF]